Immunoglobulin superfamily 6-mediated immune signature determines prognosis and immune landscape in lung adenocarcinoma

Author:

Zheng Qisi1,Wang Ting2,Jiang Gechen3,Ni Jun3,Zhang Zhi2,Tian Xinyu1

Affiliation:

1. Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University

2. Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University

3. Nanjing Drum Tower Hospital, Nanjing University Medical School

Abstract

Abstract Purpose Immunoglobulin superfamily 6 (IGSF6) is a novel member of the immunoglobulin superfamily, and the association of IGSF6 with the prognosis and antitumor immune response in lung adenocarcinoma (LUAD) remains unknown. Here, we aim to identify the role of IGSF6-mediated immune signature in the prognosis and immune landscape of LUAD. Methods IGSF6 expression in pan-cancer and LUAD data from The Cancer Genome Atlas (TCGA) was analyzed by TIMER2.0 and GEPIA2, respectively. Quantitative-real-time-PCR (qRT-PCR), western blot, and immunohistochemistry (IHC) staining were performed to confirm the results of bioinformatics. The association of IGSF6 expression and promoter methylation levels with major clinical features was analyzed by using UALCAN. Survival curves were used to assess the connection between IGSF6 expression and LUAD prognosis. The enrichment analysis was conducted by running the R software clusterProfiler package. TISIDB and TIMER2.0 were utilized to investigate the correlation between IGSF6 and tumor-infiltrating lymphocytes (TILs) in LUAD. Human Protein Atlas (HPA) and flow cytometry (FCM) were used to confirm IGSF6 localization in macrophages. Results IGSF6 levels were decreased in LUAD, and methylation levels at the IGSF6 promoter in LUAD samples increased compared to that in peritumor samples, implying a potential mechanism that leads to the aberrant expression of IGSF6 in LUAD. Low IGSF6 expression was significantly related to poor survival. In addition, IGSF6 expression was closely associated with gene sets involved in immune cell proliferation and exogenous antigen presentation, and it was positively related to immune infiltrates with antitumor activity, including M1 macrophages, dendritic cells (DCs), and T helper 1 (Th1). Furthermore, the IGSF6 protein was mainly located on the membrane of macrophages in LUAD, which enabled exogenous antigen presentation by macrophages to enhance the antitumor immune response. Conclusion IGSF6 is a biomarker of LUAD and IGSF6-mediated immune signature determines the prognosis and immune landscape of LUAD.

Publisher

Research Square Platform LLC

Reference31 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;CA Cancer J. Clin.,2021

2. R.L. Siegel, K.D. Miller, H.E. Fuchs, A. Jemal, Cancer Stat. 2021 CA Cancer J Clin 71, 7–33 (2021)

3. Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis;Li MY;Mol. Cancer,2021

4. The 2021 Global Lung Cancer Therapy Landscape;Deb D;J. Thorac. Oncol.,2022

5. Lung cancer;Brody H;Nature.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3